March’s top stories: Salix sold to Valeant, global drug development partnerships

Salix accepted Valeant's $15.8bn offer, AstraZeneca and HSCI partnered to develop new medicines for diabetes; while India introduced new Rotavirus vaccine. Pharmaceutical-technology.com wraps-up the key headlines from March 2015.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news